drugset / Trial / NCT04523701

Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial)

NCT04523701

Phase 3 Recruiting 210 enrolled Giulia Manzini
RandomizedParallel-groupTriple-blindPrevention

Summary

Bile leakage (BL) is the most frequent complication after liver resection. This study is to investigate the role of intraoperative administration of SMOFlipid 20% (fat emulsion which allows intraoperative identification of open bile ducts at the liver resection surface when it is administered retrograde through the cystic duct) in terms of prevention of postoperative BL within 30 days after surgery.

Timeline

Start
2021-03-25
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SMOFlipid Other / unclassified 20 ml Other
Subject SMOFlipid Other / unclassified 40 ml Other

Indications